Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera

[1]  G. Steinbach,et al.  Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma‐associated antigens , 1983, Journal of cutaneous pathology.

[2]  S. Ferrone,et al.  Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies , 1981, International journal of cancer.

[3]  S. Ferrone,et al.  Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. , 1981, Journal of the National Cancer Institute.

[4]  S. Ferrone,et al.  Sulfation and molecular weight of fibronectin shed by human melanoma cells. , 1981, Biochemical and biophysical research communications.

[5]  J. Brown,et al.  Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. , 1981, Journal of immunology.

[6]  S. Ferrone,et al.  Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts. , 1981, Cancer research.

[7]  S. Ferrone,et al.  Characterization of monoclonal antibodies to human melanoma-associated antigens. , 1981, Journal of the National Cancer Institute.

[8]  V. Quaranta,et al.  Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens. , 1981, Journal of immunology.

[9]  S. Ferrone,et al.  Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera. , 1981, Journal of immunology.

[10]  H. Koprowski,et al.  Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Old,et al.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Ferrone,et al.  Monoclonal antibodies to human melanoma-associated antigens. , 1980, Transplantation proceedings.

[13]  J. Mach,et al.  Common human melanoma-associated antigen(s) detected by monoclonal antibodies. , 1980, Cancer research.

[14]  J. Brown,et al.  Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Ferrone,et al.  Production and characterization of DR xenoantisera: use for detection of serum DR antigens. , 1979, Journal of immunology.

[16]  J. Allison,et al.  Serologic and immunochemical characterization of HLA-A9 xenoantisera. , 1978, Journal of immunology.

[17]  M. Herlyn,et al.  Study of antibodies against human melanoma produced by somatic cell hybrids. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Engvall,et al.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen , 1977, International journal of cancer.

[19]  P. Bornstein,et al.  Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation. , 1977, The Journal of biological chemistry.

[20]  W. Bonner,et al.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. , 1974, European journal of biochemistry.

[21]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.